VICENTE TORRES, M.D.
Osteopathic Medicine at 1 St, Rochester, MN

License number
Minnesota 22750
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511

Organization information

See more information about VICENTE TORRES at bizstanding.com

Vicente Torres MD,PHD

200 1 Ave NW, Rochester, MN 55901

Industry:
Internist
Phone:
(507) 284-2511 (Phone)
Description:
There are 36 doctors at this site. Surgery is not performed at this site.
Vicente Esbarranch Torres


Mayo Clinic - Vicente Torres MD

200 1 St SW #W4, Rochester, MN 55905

Categories:
Physicians & Surgeons
Phone:
(507) 284-9991 (Phone)

Professional information

Vicente Esbarranch Torres Photo 1

Vicente Esbarranch Torres, Rochester MN

Specialties:
Internal Medicine, Nephrology
Work:
Mayo Medical School
200 1St St Sw, Rochester, MN 55905
Education:
Universidad De Barcelona (1969)


Vicente Torres Photo 2

Dr. Vicente Torres - MD (Doctor of Medicine)

Hospitals:
200 1St Ave NW, Rochester 55901
Mayo Clinic Rochester NEP
200 1St St SW, Rochester 55905
Park Nicollet Methodist Hospital
6500 Excelsior Blvd, Saint Louis Park 55426
Saint Mary's Hospital at Amsterdam
427 Guy Park Ave, Amsterdam 12010
200 1St Ave NW, Rochester 55901
Mayo Clinic Rochester NEP
200 1St St SW, Rochester 55905
Park Nicollet Methodist Hospital
6500 Excelsior Blvd, Saint Louis Park 55426
Saint Mary's Hospital at Amsterdam
427 Guy Park Ave, Amsterdam 12010
Education:
Medical Schools
Universidad Autonoma De Barcelona, Facultad De Medicina


Vicente Torres Photo 3

Polycystic Kidney Disease Nucleic Acids And Proteins

US Patent:
2006008, Apr 27, 2006
Filed:
Jan 23, 2003
Appl. No.:
10/501834
Inventors:
Peter Harris - Rochester MN, US
Christopher Ward - Rochester MN, US
Sandro Rossetti - Rochester MN, US
Vicente Torres - Rochester MN, US
International Classification:
C12Q 1/68, C07H 21/04, C12P 21/06, C07K 14/705
US Classification:
435006000, 435069100, 435320100, 435325000, 536023500, 530350000
Abstract:
Nucleic acids and polypeptides are provided that are associated with autosomal recessive polycystic kidney disease. Antibodies against the polypeptides, vectors and host cells containing the nucleic acids, methods for using the nucleic acids, and compositions and articles of manufacture also are provided.